Skip to main content

dynein axonemal intermediate chain 1

The DNAI1 gene provides instructions for making a protein that is part of a group (complex) of proteins called dynein. This complex functions within cell structures called cilia. Cilia are microscopic, finger-like projections that stick out from the surface of cells. Coordinated back and forth movement of cilia can move the cell or the fluid surrounding the cell. Dynein produces the force needed for cilia to move. 

Video picks for Genes
Video library

Normal function

The DNAI1 gene provides instructions for making a protein that is part of a group (complex) of proteins called dynein. This complex functions within cell structures called cilia. Cilia are microscopic, finger-like projections that stick out from the surface of cells. Coordinated back and forth movement of cilia can move the cell or the fluid surrounding the cell. Dynein produces the force needed for cilia to move. 

Within the core of cilia (the axoneme), dynein complexes are part of structures known as inner dynein arms (IDAs) and outer dynein arms (ODAs) depending on their location. Coordinated movement of the dynein arms causes the entire axoneme to bend back and forth. IDAs and ODAs have different combinations of protein components (subunits) that are classified by weight as heavy, intermediate, or light chains. The DNAI1 gene provides instructions for making intermediate chain 1, which is found in ODAs. Other subunits are produced from different genes.

Conditions referring to this gene or chromosome

Other names

dynein, axonemal, intermediate chain 1

dynein, axonemal, intermediate polypeptide 1

Patient picks for Genes

Related patient information and medicines

Thrombophilia

Patient information leaflet

Thrombophilia

The body has a natural clotting process in the blood, which is altered in thrombophilia. Thrombophilia refers to a group of conditions where the blood clots more easily than normal. The body has a natural clotting process in the blood, which is altered in thrombophilia. It helps to stop bleeding if you have an injury such as a cut. When a blood.

Macular degeneration

Patient information leaflet

Macular degeneration

Age-related macular degeneration is the most common cause of sight impairment in those aged over 50. It causes a gradual loss of central vision, which is needed for detailed work and for things like reading and driving. Edge vision (peripheral vision) is not lost. Macular degeneration (also known as age-related macular degeneration) occurs when.

Pituitary gland disorders

Patient information leaflet

Pituitary gland disorders

This leaflet gives a brief overview of the pituitary gland and the hormones it makes. The pituitary gland is found at the base of the brain and is 'pea-sized'. The pituitary gland is an overall controller of a number of other glands in the body, overseeing the function of these organs through hormones. Some of the pituitary gland disorders.

Crohn's disease

Patient information leaflet

Crohn's disease

Crohn's disease is a condition that causes inflammation of the wall of the gut (gastrointestinal tract). Crohn's disease is a condition that causes inflammation of the wall of the gut (gastrointestinal tract). Crohn's disease is a lifelong condition with flare-ups from time to time. Crohn's disease is generally managed by a specialist.

Myeloma

Patient information leaflet

Myeloma

Myeloma is a cancer that affects cells, called plasma cells, in the bone marrow. Bone marrow is the spongy tissue at the centre of some bones that produces the body's blood cells. Dr Krishna Vakharia , 10th April 2025 The National Institute for Health and Care Excellence (NICE) has updated its guidance on assessment for myeloma in all ages.

Chronic myeloid leukaemia

Patient information leaflet

Chronic myeloid leukaemia

Chronic myeloid leukaemia (CML) is sometimes called chronic myelogenous leukaemia, chronic granulocytic leukaemia, or chronic myelocytic leukaemia. What is chronic myeloid leukaemia. Chronic myeloid leukaemia (CML) is sometimes called chronic myelogenous leukaemia, chronic granulocytic leukaemia, or chronic myelocytic leukaemia. CML develops due.

Further reading and references

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 10 Dec 2025 | Latest version
  • 1 Apr 2014 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.